NanoViricides, Inc. (NNVC) Targeting Commercially Important Viral Diseases with Unique Nanomedicine Technology
NanoViricides, Inc. (NYSE MKT: NNVC) is taking a new approach to combatting some of the world’s most commercially important viral diseases through the development of nanotechnology-based biomimetic anti-viral medicines called NanoViricides®. These microscopic agents are specially designed to fool viruses into attaching to them, much like they attach to the receptors of human cells. However, once attached, NanoViricides wrap around the virus, trapping the infectious organism and destroying its coat proteins. Without coat proteins, viruses are unable to bind to cells. In other words, the company’s innovative antiviral technology renders targeted viruses completely innocuous and effectively destroyed. Although NNVC’s licensed…